Prakash Balan, MD, JD; Tom C. Nguyen, MD; H. Vernon Anderson, MD
Prakash Balan, MD, JD; Tom C. Nguyen...
Born from surgical risk considerations, TAVR ultimately will be defined by individualized outcomes. As we treat severe aortic stenosis among ever lower-risk patients, we will need to retain both TAVR and SAVR as possible options.
Born from surgical risk considerations, TAVR ultimately will be defined by individualized outcomes. As we treat severe aortic stenosis among ever lower-risk patients, we will need to retain both TAVR and SAVR as possible options.